Adventrx To Begin Phase III Trial Of CoFactor In Q2
Phase III trial of the biomodulator with the chemotherapeutic 5-FU will compare CoFactor to leucovorin.
Phase III trial of the biomodulator with the chemotherapeutic 5-FU will compare CoFactor to leucovorin.